CorMedix Inc.'s (NASDAQ:CRMD) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
CorMedix's (NASDAQ:CRMD) stock is up by a considerable 25% over the past three months. As most would know, fundamentals...
| Ticker |
CRMD
|
| CIK | 0001410098 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS, NJ, 07922 |
| Website | cormedix.com |
| Phone | 908-517-9500 |
| CEO | Joseph Todisco |
| Employees | 30 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
CorMedix Inc.'s (NASDAQ:CRMD) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?CorMedix's (NASDAQ:CRMD) stock is up by a considerable 25% over the past three months. As most would know, fundamentals... CorMedix Inc. To Participate In The Jefferies Global Healthcare ConferenceBERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the Jefferies Global Healthcare Conference, taking place in New York on June 3 - 5, 2025. Jefferies Global Healthcare ConferenceDate:Thursday, June 5, 2025Time:3:45p.m. EDTFormat:PresentationWebcast:Link About CorMedix CorMedix Inc. is a biopharmaceut CorMedix Inc. to Participate in the RBC Global Healthcare ConferenceBERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC Capital Markets Global Healthcare Conference, taking place in New York on May 20-21, 2025. RBC Capital Markets Global Healthcare ConferenceDate:Wednesday, May 21, 2025Time:3:05p.m. EDTFormat:Fireside ChatWebcast:Link About CorMedixCorMedix Inc Biotech Alert: Searches spiking for these stocks todayThese names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Galmed Pharmaceuticals (GLMD), 353% surge in interest Protagenic Therapeutics (PTIX), 345% surge in interest Hepion Pharmaceuticals (HEPA), 310% surge in interest Rigel Pharmaceuticals (RIGL), 290% surge in interest Bolt Biotherapeutics (BOLT), 274% surge in interest Palatin Technologies (PTN), 274% surge in interest Krystal Biotech (KRYS), 240% surge in CorMedix Inc. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting NextCorMedix Inc. ( NASDAQ:CRMD ) just released its first-quarter report and things are looking bullish. It was overall a... |